Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wei-Jun Fu

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Zhonghua Nan Ke Xue = National Journal of Andrology|August 11, 2025
[Lymph node metastasis in the prostatic anterior fat pad and prognosis after robot-assisted radical prostatectomy]Zhou-Jie Ye, Yong Song, Jin-Peng Shao, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|May 15, 2013
[The efficacy and safety analysis of bortezomib retreatment in 76 patients with relapsed/refractory multiple myeloma]Jing Lu, Jian Hou, Chun-yang Zhang, et al.
Chinese Medical Journal|April 4, 2015
Study of clinical practical model of urinary system injuryGang Li, Yuan-Yi Wu, Wei-Jun Fu, et al.
Circulation|September 10, 2021
Doxycycline Combined With Bortezomib-Cyclophosphamide-Dexamethasone Chemotherapy for Newly Diagnosed Cardiac Light-Chain Amyloidosis: A Multicenter Randomized Controlled TrialKai-Ni Shen, Wei-Jun Fu, Yu Wu, et al.
Chinese Medical Journal|July 16, 2019
Comparison of outcomes after human leukocyte antigen-matched and haploidentical hematopoietic stem-cell transplantation for multiple myelomaYao Chen, Wei-Jun Fu, Lan-Ping Xu, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 17, 2019
Exploratory trial of a biepitopic CAR T-targeting B cell maturation antigen in relapsed/refractory multiple myelomaJie Xu, Li-Juan Chen, Shuang-Shuang Yang, et al.
Journal of Hematology & Oncology|July 6, 2022
Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2)Wan-Hong Zhao, Bai-Yan Wang, Li-Juan Chen, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Zhonghua Nan Ke Xue = National Journal of Andrology|August 11, 2025
[Lymph node metastasis in the prostatic anterior fat pad and prognosis after robot-assisted radical prostatectomy]Zhou-Jie Ye, Yong Song, Jin-Peng Shao, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|May 15, 2013
[The efficacy and safety analysis of bortezomib retreatment in 76 patients with relapsed/refractory multiple myeloma]Jing Lu, Jian Hou, Chun-yang Zhang, et al.
Chinese Medical Journal|April 4, 2015
Study of clinical practical model of urinary system injuryGang Li, Yuan-Yi Wu, Wei-Jun Fu, et al.
Circulation|September 10, 2021
Doxycycline Combined With Bortezomib-Cyclophosphamide-Dexamethasone Chemotherapy for Newly Diagnosed Cardiac Light-Chain Amyloidosis: A Multicenter Randomized Controlled TrialKai-Ni Shen, Wei-Jun Fu, Yu Wu, et al.
Chinese Medical Journal|July 16, 2019
Comparison of outcomes after human leukocyte antigen-matched and haploidentical hematopoietic stem-cell transplantation for multiple myelomaYao Chen, Wei-Jun Fu, Lan-Ping Xu, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 17, 2019
Exploratory trial of a biepitopic CAR T-targeting B cell maturation antigen in relapsed/refractory multiple myelomaJie Xu, Li-Juan Chen, Shuang-Shuang Yang, et al.
Journal of Hematology & Oncology|July 6, 2022
Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2)Wan-Hong Zhao, Bai-Yan Wang, Li-Juan Chen, et al.
Pageof 8